---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-287901"
form_type: "8-K"
ticker: null
cik: "0001694665"
company_name: "Evelo Biosciences, Inc."
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T18:47:48.505302+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Evelo Biosciences receives Nasdaq delisting notice; will not appeal; trading suspension Dec 12

## Summary
- Nasdaq determined Evelo is a 'public shell' after board resignations, CEO/CFO separation, and dissolution plan.
- Company fails $50M market value, $15M public float, and $1 bid price requirements for continued listing.
- Trading suspended at open on Dec 12, 2023; Form 25-NSE to follow; company will not appeal.
- Stockholders may realize no value as company proceeds with dissolution.

## SEC filing metadata
- accession: 0001193125-23-287901
- form_type: 8-K
- cik: 0001694665
- company_name: Evelo Biosciences, Inc.
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1694665/000119312523287901/0001193125-23-287901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1694665/000119312523287901/d622413d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-287901
- JSON: https://secwatch.observer/filing/0001193125-23-287901.json
- Plain text: https://secwatch.observer/filing/0001193125-23-287901.txt

## Key facts
- Listing & Compliance Notices
  Evelo Biosciences, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5605(b)(1), 5605(c)(2), 5605(d)(2), 5605(e)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101, 5605(b)(1), 5605(c)(2), 5605(d)(2), 5605(e)(1)
  source text: nd (iii) the separation of the Company’s Chief Executive Officer and Chief Financial Officer from the Company, it is the Staff’s belief that the Company no longer has an operating business and is a “public shell” as that term is defined in Nasdaq Listing Rule 5101. Terms used but defined herein are as defined under the rules of Nasdaq. The Staff also indicated that that the Company is not compliant with the following requirements for continued listing on Nasdaq: (1) $50,000,000 minimum Market Value of Listed Securities, (2) $15,000,000 minimum Market Value of Publicly Held Shares and (3) a minimum bid price of $1 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1694665/000119312523287901/0001193125-23-287901-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.